Distribution and Drug Resistance of Bacterial Pathogens Associated with Lower Respiratory Tract Infection in Children and the Effect of COVID-19 on the Distribution of Pathogens

By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogen...

Full description

Saved in:
Bibliographic Details
Published inThe Canadian journal of infectious diseases & medical microbiology Vol. 2022; pp. 1 - 17
Main Authors Zhu, Xuan, Ye, Ting, Zhong, Hong, Luo, Yaxuan, Xu, Jian, Zhang, Qin, Luo, Xiaobo, Wang, Qin, Zhang, Liyuan, Song, Peipei, Zhang, Jun
Format Journal Article
LanguageEnglish
Published Egypt Hindawi 29.03.2022
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text
ISSN1712-9532
1918-1493
DOI10.1155/2022/1181283

Cover

Abstract By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children’s Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 P<0.01, Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1–6 P<0.01, and Haemophilus influenzae was highly isolated in children over 1 P<0.01. The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants p<0.05. Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant P<0.01. Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant P<0.01. The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant P<0.01. The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance.
AbstractList By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 (P<0.01), Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1-6 (P<0.01), and Haemophilus influenzae was highly isolated in children over 1 (P<0.01). The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants (p<0.05). Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant (P<0.01). Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant (P<0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant (P<0.01). The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance.
By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. , , , were highly isolated in the group of infants aged 0-1 ( < 0.01), and were highly isolated in children aged 1-6 ( < 0.01), and was highly isolated in children over 1 ( < 0.01). The isolation rates of , , , , and in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants ( < 0.05). was highly isolated in spring and summer, and was highly isolated in autumn and winter, while the infection of was mainly concentrated in winter. This difference was statistically significant ( < 0.01). Affected by the COVID-19 pandemic, the isolation rates of and were significantly lower than those before the pandemic, and the isolation rate of was significantly higher. The difference was statistically significant ( < 0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of , , and were higher than those in other departments. The differences were statistically significant ( < 0.01). The results of drug sensitivity test showed that the drug resistance of and was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. is highly resistant to penicillins and macrolides and susceptible to vancomycin. resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of and to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance.
By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children’s Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 P < 0.01 , Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1–6 P < 0.01 , and Haemophilus influenzae was highly isolated in children over 1 P < 0.01 . The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants p < 0.05 . Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant P < 0.01 . Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant P < 0.01 . The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant P < 0.01 . The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance.
By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 (P < 0.01), Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1-6 (P < 0.01), and Haemophilus influenzae was highly isolated in children over 1 (P < 0.01). The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants (p < 0.05). Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant (P < 0.01). Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant (P < 0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant (P < 0.01). The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance.By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 (P < 0.01), Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1-6 (P < 0.01), and Haemophilus influenzae was highly isolated in children over 1 (P < 0.01). The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants (p < 0.05). Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant (P < 0.01). Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant (P < 0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant (P < 0.01). The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implement
By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae , Escherichia coli , Enterobacter cloacae , and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 ( P < 0.01), Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1–6 ( P < 0.01), and Haemophilus influenzae was highly isolated in children over 1 ( P < 0.01). The isolation rates of Enterobacteriaceae , Acinetobacter baumannii , Pseudomonas aeruginosa , Stenotrophomonas maltophilia , Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants ( p < 0.05). Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant ( P < 0.01). Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant ( P < 0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae , Escherichia coli , Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant ( P < 0.01). The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance.
Audience Academic
Author Zhang, Liyuan
Zhu, Xuan
Song, Peipei
Ye, Ting
Xu, Jian
Luo, Yaxuan
Zhong, Hong
Luo, Xiaobo
Zhang, Qin
Zhang, Jun
Wang, Qin
AuthorAffiliation 2 Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, China
1 Department of Clinical Laboratory, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China
3 Department of Pediatric Hematology and Oncology Department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China
AuthorAffiliation_xml – name: 3 Department of Pediatric Hematology and Oncology Department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China
– name: 2 Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, China
– name: 1 Department of Clinical Laboratory, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China
Author_xml – sequence: 1
  givenname: Xuan
  orcidid: 0000-0003-2657-6000
  surname: Zhu
  fullname: Zhu, Xuan
  organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
– sequence: 2
  givenname: Ting
  surname: Ye
  fullname: Ye, Ting
  organization: Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of EducationChongqing Medical UniversityChongqing 400016Chinacqmu.edu.cn
– sequence: 3
  givenname: Hong
  surname: Zhong
  fullname: Zhong, Hong
  organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
– sequence: 4
  givenname: Yaxuan
  surname: Luo
  fullname: Luo, Yaxuan
  organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
– sequence: 5
  givenname: Jian
  surname: Xu
  fullname: Xu, Jian
  organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
– sequence: 6
  givenname: Qin
  surname: Zhang
  fullname: Zhang, Qin
  organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
– sequence: 7
  givenname: Xiaobo
  surname: Luo
  fullname: Luo, Xiaobo
  organization: Department of Pediatric Hematology and Oncology DepartmentChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
– sequence: 8
  givenname: Qin
  orcidid: 0000-0002-1304-4753
  surname: Wang
  fullname: Wang, Qin
  organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
– sequence: 9
  givenname: Liyuan
  surname: Zhang
  fullname: Zhang, Liyuan
  organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
– sequence: 10
  givenname: Peipei
  surname: Song
  fullname: Song, Peipei
  organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
– sequence: 11
  givenname: Jun
  surname: Zhang
  fullname: Zhang, Jun
  organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35368516$$D View this record in MEDLINE/PubMed
BookMark eNp9k91v0zAQwCM0xD7gjWdkMQkhQbdcPhznBal0AypVGkITr9bVsRtXqd3ZLtP-LP5DnLYb7TRQHhLd_e539sU-Tg6MNTJJXkN6BlCW51maZecADDKWP0uOoAY2gKLOD-J3BdmgLvPsMDn2fp6mOc2gepEc5mVOWQn0KPl9oX1weroK2hqCpiEXbjUjP6SPcTRCEqvIZxRBOo0d-Y6htTNpPBl6b4XGIBtyq0NLJvZWur5uqR0G6-7ItYtlZGyUFGu5NmTU6q5xctMotJJcqj7b9xhd_RxfDKAmkewze-uK-YfOL5PnCjsvX23fJ8n1l8vr0bfB5OrreDScDERJ6zBQhVKQUpZXFPIpKzFnSsRt05wKhcBEWikosQHFVMUiOMVCiAwFsqapWX6SjDfaxuKcL51eoLvjFjVfB6ybcXRBi07ytKgaUWeVmKa0qCGrUykrwUAWJYppCdH1aeNarqYL2QhpgsNuT7qfMbrlM_uLs5qWVV5EwfutwNmblfSBL7QXsuvQSLvyPKMFrQsKcXcnyekjdG5XzsRJ9RSLxyRif6kZxg1oo2zsK3opHzIogEVTP4O3T1BiqW_4LnT2BBSfRi60iGdV6Rjfs77bKWgldqH1tlv_ab8Pvtkd28O87k9vBLINIJz13knFhQ7Ye-ISdMch5f0V4f0V4dsrEos-Piq69_4D_7DBW20avNX_p_8A8_Mb6g
CitedBy_id crossref_primary_10_2147_IDR_S400207
crossref_primary_10_2147_IDR_S397513
crossref_primary_10_1002_hsr2_70214
crossref_primary_10_2147_IDR_S423580
crossref_primary_10_1016_j_ijmmb_2024_100742
crossref_primary_10_1007_s15010_024_02308_8
crossref_primary_10_1186_s13052_025_01859_2
crossref_primary_10_1038_s41598_024_62728_2
crossref_primary_10_1002_jmv_70063
crossref_primary_10_3390_microorganisms11102542
crossref_primary_10_1515_labmed_2022_0104
crossref_primary_10_1089_mdr_2024_0064
Cites_doi 10.1093/ofid/ofaa307
10.1016/S2214-109X(19)30071-3
10.1186/s12879-015-1188-1
10.1093/cid/cir531
10.1016/s2214-109x(18)30491-1
10.1093/aje/kwu002
10.1016/j.vaccine.2017.11.018
10.3760/cma.j.issn.1001-0939.2018.04.007
10.1001/jamapediatrics.2021.4217
10.2478/jvetres-2020-0057
10.3389/fmicb.2020.575707
10.1016/j.cmi.2021.05.034
10.1007/s10096-018-3314-7
10.1016/S1473-3099(18)30310-4
10.3390/vaccines9050474
10.1371/journal.pone.0237871
10.1126/science.336.6083.795
10.1002/ppul.22661
10.1007/s00038-017-1007-0
10.1186/s12942-016-0061-9
10.1016/s0140-6736(12)61901-1
10.1136/bmj.l440
10.1093/jac/dkw332
10.1073/pnas.2004933118
10.1016/s1473-3099(16)30527-8
10.1016/s0140-6736(15)00474-2
10.1016/j.cmi.2020.04.033
10.1016/S1473-3099(17)30396-1
10.1371/journal.pone.0195098
10.1128/aac.00075-16
10.22038/ijorl.2019.34363.2137
10.1371/journal.pmed.1003208
10.1016/j.prrv.2020.06.016
10.1007/s40272-017-0257-x
10.1016/j.jiac.2016.11.001
10.1016/s2214-109x(20)30229-1
10.1016/j.envint.2019.105150
10.1038/s41587-019-0156-5
ContentType Journal Article
Copyright Copyright © 2022 Xuan Zhu et al.
COPYRIGHT 2022 John Wiley & Sons, Inc.
Copyright © 2022 Xuan Zhu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
Copyright © 2022 Xuan Zhu et al. 2022
Copyright_xml – notice: Copyright © 2022 Xuan Zhu et al.
– notice: COPYRIGHT 2022 John Wiley & Sons, Inc.
– notice: Copyright © 2022 Xuan Zhu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
– notice: Copyright © 2022 Xuan Zhu et al. 2022
DBID RHU
RHW
RHX
AAYXX
CITATION
NPM
3V.
7T7
7X7
7XB
8FD
8FI
8FJ
8FK
8FQ
8FV
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
K9.
M0S
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.1155/2022/1181283
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Canadian Business & Current Affairs Database
Canadian Business & Current Affairs Database (Alumni)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Environmental Sciences and Pollution Management
ProQuest Central
CBCA Complete (Alumni Edition)
ProQuest One Sustainability
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
CBCA Complete
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


PubMed
CrossRef
MEDLINE - Academic

Publicly Available Content Database

Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1918-1493
Editor Manilal, Aseer
Editor_xml – sequence: 1
  givenname: Aseer
  surname: Manilal
  fullname: Manilal, Aseer
EndPage 17
ExternalDocumentID oai_doaj_org_article_047dc927cb06491290ee7c81e45acb51
PMC8965734
A814186638
35368516
10_1155_2022_1181283
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: Chengdu Women’s and Children’s Central Hospital
– fundername: Sichuan Provincial Medical Youth Innovative Scientific Research Foundation of China
  grantid: Q20069
– fundername: Chengdu Women's and Children's Central Hospital
GroupedDBID ---
19Q
29B
3V.
53G
5GY
5VS
6J9
7X7
8FI
8FJ
8FQ
AAFWJ
AAIKC
AAJEY
AAMNW
ABDBF
ABUWG
ACIHN
ADBBV
AEAQA
AENEX
AFKRA
AFPKN
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIK
DWQXO
E3Z
EBS
EJD
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
ICQ
IHR
INH
ITC
KQ8
OK1
P6G
PIMPY
PQQKQ
PROAC
RHU
RHW
RHX
RPM
TR2
TUS
UKHRP
0R~
24P
AAYXX
ACCMX
ACUHS
AEUYN
CITATION
IHW
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H13
IPNFZ
NPM
RIG
PMFND
7T7
7XB
8FD
8FK
AZQEC
C1K
FR3
K9.
M~E
P64
PKEHL
PQEST
PQUKI
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c569t-f4ff106837613b85a38fc536636cfa18c07f15ad1f8f78068ba4cc2aca8dd983
IEDL.DBID 7X7
ISSN 1712-9532
IngestDate Wed Aug 27 01:27:10 EDT 2025
Thu Aug 21 18:42:25 EDT 2025
Fri Sep 05 13:13:42 EDT 2025
Wed Aug 13 04:05:42 EDT 2025
Tue Jun 17 22:02:21 EDT 2025
Tue Jun 10 15:40:57 EDT 2025
Tue Jun 10 20:59:53 EDT 2025
Thu May 22 21:23:25 EDT 2025
Mon Jul 21 05:45:48 EDT 2025
Tue Jul 01 02:53:54 EDT 2025
Thu Apr 24 23:05:21 EDT 2025
Sun Jun 02 19:21:27 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
https://creativecommons.org/licenses/by/4.0
Copyright © 2022 Xuan Zhu et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c569t-f4ff106837613b85a38fc536636cfa18c07f15ad1f8f78068ba4cc2aca8dd983
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Aseer Manilal
ORCID 0000-0002-1304-4753
0000-0003-2657-6000
OpenAccessLink https://www.proquest.com/docview/2648812616?pq-origsite=%requestingapplication%
PMID 35368516
PQID 2648812616
PQPubID 2032235
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_047dc927cb06491290ee7c81e45acb51
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8965734
proquest_miscellaneous_2646946166
proquest_journals_2648812616
gale_infotracmisc_A814186638
gale_infotraccpiq_814186638
gale_infotracacademiconefile_A814186638
gale_healthsolutions_A814186638
pubmed_primary_35368516
crossref_citationtrail_10_1155_2022_1181283
crossref_primary_10_1155_2022_1181283
hindawi_primary_10_1155_2022_1181283
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-03-29
PublicationDateYYYYMMDD 2022-03-29
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-29
  day: 29
PublicationDecade 2020
PublicationPlace Egypt
PublicationPlace_xml – name: Egypt
– name: Oakville
PublicationTitle The Canadian journal of infectious diseases & medical microbiology
PublicationTitleAlternate Can J Infect Dis Med Microbiol
PublicationYear 2022
Publisher Hindawi
John Wiley & Sons, Inc
Wiley
Publisher_xml – name: Hindawi
– name: John Wiley & Sons, Inc
– name: Wiley
References 22
GBD 2015 Eastern Mediterranean Region Lower Respiratory Infections Collaborators (4) 2018; 63
23
24
25
26
27
28
29
M. Pfeifer (5) 2020; 1–11
M. F. Zuo (31) 2014; 16
30
10
32
11
33
12
34
13
35
14
36
15
37
16
38
17
39
18
19
K. M. Hare (21) 2010; 53
1
2
3
6
7
8
9
40
41
20
References_xml – ident: 20
  doi: 10.1093/ofid/ofaa307
– ident: 14
  doi: 10.1016/S2214-109X(19)30071-3
– ident: 22
  doi: 10.1186/s12879-015-1188-1
– ident: 10
  doi: 10.1093/cid/cir531
– ident: 23
  doi: 10.1016/s2214-109x(18)30491-1
– ident: 29
  doi: 10.1093/aje/kwu002
– ident: 1
  doi: 10.1016/j.vaccine.2017.11.018
– ident: 30
  doi: 10.3760/cma.j.issn.1001-0939.2018.04.007
– ident: 6
  doi: 10.1001/jamapediatrics.2021.4217
– ident: 36
  doi: 10.2478/jvetres-2020-0057
– ident: 37
  doi: 10.3389/fmicb.2020.575707
– ident: 18
  doi: 10.1016/j.cmi.2021.05.034
– ident: 19
  doi: 10.1007/s10096-018-3314-7
– ident: 2
  doi: 10.1016/S1473-3099(18)30310-4
– ident: 26
  doi: 10.3390/vaccines9050474
– ident: 34
  doi: 10.1371/journal.pone.0237871
– ident: 39
  doi: 10.1126/science.336.6083.795
– ident: 13
  doi: 10.1002/ppul.22661
– volume: 63
  start-page: 97
  issue: 1
  year: 2018
  ident: 4
  article-title: Burden of lower respiratory infections in the eastern mediterranean region between 1990 and 2015: findings from the global burden of disease 2015 study
  publication-title: International Journal of Public Health
  doi: 10.1007/s00038-017-1007-0
– ident: 11
  doi: 10.1186/s12942-016-0061-9
– volume: 16
  start-page: 1226
  issue: 12
  year: 2014
  ident: 31
  article-title: [Pathologic bacterial distribution and antibiotic resistance in induced sputum of infants aged from 1 to 3 months with lower respiratory tract infection]
  publication-title: Chinese Journal of Contemporary Pediatrics
– ident: 3
  doi: 10.1016/s0140-6736(12)61901-1
– ident: 15
  doi: 10.1136/bmj.l440
– ident: 33
  doi: 10.1093/jac/dkw332
– ident: 25
  doi: 10.1073/pnas.2004933118
– ident: 38
  doi: 10.1016/s1473-3099(16)30527-8
– ident: 9
  doi: 10.1016/s0140-6736(15)00474-2
– ident: 24
  doi: 10.1016/j.cmi.2020.04.033
– ident: 12
  doi: 10.1016/S1473-3099(17)30396-1
– ident: 17
  doi: 10.1371/journal.pone.0195098
– volume: 53
  start-page: 151
  issue: 3-4
  year: 2010
  ident: 21
  article-title: The bacteriology of lower respiratory infections in Papua New Guinean and Australian indigenous children
  publication-title: Papua New Guinea Medical Journal
– ident: 40
  doi: 10.1128/aac.00075-16
– ident: 32
  doi: 10.22038/ijorl.2019.34363.2137
– ident: 16
  doi: 10.1371/journal.pmed.1003208
– ident: 8
  doi: 10.1016/j.prrv.2020.06.016
– ident: 27
  doi: 10.1007/s40272-017-0257-x
– ident: 35
  doi: 10.1016/j.jiac.2016.11.001
– ident: 7
  doi: 10.1016/s2214-109x(20)30229-1
– ident: 28
  doi: 10.1016/j.envint.2019.105150
– ident: 41
  doi: 10.1038/s41587-019-0156-5
– volume: 1–11
  year: 2020
  ident: 5
  article-title: [COVID-19 pneumonia]
  publication-title: The Gastroenterologist: Zeitschrift fur Gastroenterologie und Hepatologie
SSID ssj0036217
Score 2.333462
Snippet By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
hindawi
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Acinetobacter baumannii
Age
Age differences
Ampicillin
Antibiotics
Bacteria
Bacteria, Pathogenic
Bacterial infections
Cephalosporins
Children
Communicable diseases in children
Cotrimoxazole
COVID-19
Disease
Disinfection
Distribution
Drug resistance
Drug resistance in microorganisms
E coli
Enterobacter cloacae
Enterobacteriaceae
Epidemics
Escherichia coli
Gender
Gram-negative bacteria
Gram-positive bacteria
Haemophilus influenzae
Health services
Hospitals
Hygiene
Infants
Infectious diseases
Klebsiella
Klebsiella pneumoniae
Laboratories
Low income groups
Medical prognosis
Medical treatment
Moraxella catarrhalis
Mortality
Opportunist infection
Outdoor air quality
Pandemics
Pathogens
Pediatric research
Pediatrics
Penicillin
Personal hygiene
Pneumonia
Pseudomonas aeruginosa
Public health
Respiration
Respiratory tract
Respiratory tract diseases
Respiratory tract infection
Respiratory tract infections
Risk factors
Sensitivity
Sensitivity analysis
Software
Staphylococcus aureus
Statistical analysis
Statistical methods
Strengthening
Streptococcus pneumoniae
Sulfonamides
Tetracyclines
Trends
Tuberculosis
Vaccination
Vancomycin
Viral diseases
Winter
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJRAXxJulCxipiAOKmocd28d2l6pFFBAqqDfLT7oSypburvhd_ENmEifaIFAvXHfG69gzHs8kM98QssfzquQuD5kRnmfMmpgZX8dMhcCD4IWLHAucTz_Ux1_Yu3N-vtXqC3PCOnjgbuP2cya8U6VwFi5PhW9NQhBOFoFx42xbPF3mKu-Dqc4Gg1UuRJ_mzjlG-OU-lliWshpdQC1O_2CNb15gHPxz8Tdv88-kya1b6OguuZPcR3rQPfY9ciM098mt0_SB_AH5NUcg3NTDiprG0_nV5hv9HFboJ4KA6TLSww6hGf7nE_h_S1ChFe3FFDzFV7P0PXZPw3H9h3h6hvVU9CQlbzV00dBZqgRvJwJPknZYyDjH7OPXk3lWKAqcSBk9F9CHmR-Ss6O3Z7PjLHVlyByv1TqLLEaIIyGwBU_ASm4qGR2vwHOpXTSFdLmIBTe-iDIKCYzWMOdK44z0XsnqEdlplk14Qiiz3ltZWSNry2KFzklZK-WEK_MgXT0hb3pJaZcQy7FxxnfdRi6ca5SrTnKdkFcD92WH1PEPvkMU-sCD-NrtD6B1Ommdvk7rJuQFqozuilUHK6EPZMEQQrCSE_K65UA7AQ_tTCp3gKUj4taIc3fE6S4XP_QWdTqiwul3o8F7SWmvWfS012idjNRKY3IjUOsCdvrlQMYJMPGuCctNy1MrBizA87g7AMNEFcfuBThajI7GaGvHlGZx0UKYS1VzUbGn_0MWu-Q2LhUTA0s1JTvrq014Bp7i2j5vjcJvR4pkdQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJBAviO-VFTDSEA8oIk5sx37cWqYOMUBTQX2zHMdmlVA61lb8XfyH3CVOtAwQPCb3c-zkzudzfB-EHIg0z4RLfWKLSiS8tCGxlQyJ9l74QjAXBAY4n36Qs8_83UIsYpKk9e9H-LDa4fY8e4PxkbAS7pAdJVF4z2aLTuGCCm4K67KCZXgamXX-7dfaDlaeJkF_r4ZvnuMG-MfyT2bmdW_JK8vP8V1yJ9qN9LBl9D1yw9f3ya3TeDL-gPycYgbcWLyK2rqi08vtV3rm12ggAmfpKtCjNjUzPOcTGH4rkJ017fjjK4r_ZOl7LJuG7boTeDrHQCp6Er22arqs6SSGgDcdgQlJ2yTI2Mfk45eTacI0BSRSBuMCet_zQzI_fjufzJJYjiFxQupNEngIsIGEHS2YAKUSNlfBiRxMFumCZcqlRWDCViyoUCgAlpY7l1lnVVVplT8iu_Wq9nuE8rKqSpWXVsmShxytkkxq7QqXpV45OSKvO04ZF1OVY8WMb6bZsghhkK8m8nVEXvboizZFx19wR8j0HoOJtZsbIGwmzlOT8qJyOitcCbaaxp903hdOMc-FdaVgI_IcRca0Uaq9ejCHinHMHZirEXnVIFBBwKCdjXEO8OqYamuA3B8g3cXyu7lCHQ-oMO3doPFBFNp_vPS4k2gTtdPaoFcjUCWDL_2iJ2MH6HFX-9W2wUjNAQKYx-0E6DvKBZYtwNbFYGoMPu2QUi_Pm9zlSktR5PzJ_41-n9zGS_T5y_SY7G4ut_4pGIGb8lmjAn4BsYtT0w
  priority: 102
  providerName: Hindawi Publishing
Title Distribution and Drug Resistance of Bacterial Pathogens Associated with Lower Respiratory Tract Infection in Children and the Effect of COVID-19 on the Distribution of Pathogens
URI https://dx.doi.org/10.1155/2022/1181283
https://www.ncbi.nlm.nih.gov/pubmed/35368516
https://www.proquest.com/docview/2648812616
https://www.proquest.com/docview/2646946166
https://pubmed.ncbi.nlm.nih.gov/PMC8965734
https://doaj.org/article/047dc927cb06491290ee7c81e45acb51
Volume 2022
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1rb9Mw0IJNIKQJwXisrBQjDfEBRauTOHY-obXd1AIbU1VQv0WOY2-VUNL1IX4X_5C7xAkL4vGlUnrn2I7P57vzPQg54v3A57pvPCUy7oWpsp7KIuvFxnAjONOWY4Dz-UU0_hJ-mPO5M7itnVtlzRNLRp0VGm3kx-iJBYdRxKL3yxsPq0bh7aoroXGX7DKQRLB0g5g3Chfw5rLiLhPMx2tKv3Z85xx1fv8Ygy59GbSOpDJzf8Of712jZvx98Sf583c3ylvn0tkj8tAJlPSkooDH5I5d7ZP75-7KfJ_sVYY5WsUbPSE_Rpgq11W5oirP6Gi1vaJTs0ZJEkiAFpYOqhzO8N5LkBALILI1rRfSZBSNt_QT1lfDdvVVPZ1hxBWdOPeunC5yOnSx4mVHIGvSKlsy9jH8_HUy8lhMARMhrXEBvOn5KZmdnc6GY8_VbfA0j-KNZ0NrQdME1RdkhVRyFUireQCyTaStYlL3hWVcZcxKKyQgpirU2ldaySyLZfCM7ORFbg4IDdMsS2WQKhmloQ1QfPGjONZC-30jddQh7-qVS7TLaY6lNb4lpW7DeYLrnLh17pA3DfayyuXxF7wBEkGDgxm4yz-K1VXiNnTSD0WmY1_oFIS6GK15xggtmQm50ilnHfIKSSipwlkbPpKcSBZiksFAdsjbEgM5CQxaKxcQAVPHnFwtzMMWpl4ubpJb0G4LCvxBtxofOSL-z6S7NYUnjo2tk1-brkNeN2DsAF3zclNsS5woDgEFcJ5XG6LpKOBY3wBbi9ZWaX3aNiRfXJdJzmUccRGEL_49rEPyACeBToF-3CU7m9XWvAQpcZP2SlbQI7uD04vLKTyNJh97pcUFfqfj-U828Gew
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1BqduEgIwbiVFWakTTygaE1iJ87DhNZ2U8vaMk0F7c1yfNkqobTrRROfxQfwb_gkTlgQl6e99hzHdn18bj4XhHZpOwyobGtPxIp6JBXGEyoyXqI11TH1paGQ4DwaR_3P5OM5Pd9AP8pcGAirLHlizqjVTIKPfB8isawwivzow_zKg65R8LpattAQrrWCOshLjLnEjhP97dqacMuDQc-e914QHB9Nun3PdRnwJI2SlWeIMdYusoaalWwpoyJkRtLQSuJIGuEz2Y6NT4XyDTMxs4ipIFIGQgqmVMJC-9k7aJOA_6SBNjtH49OzUhRY4ZC3_PVjP4B30qCMvKcUnA7BPmR9BiysycS8dUAlIO5egml-Pf2TAvx7HOcNwXj8GD1yGi0-LEjwCdowiy10b-Te7LfQw8IziIuEp6foew9q9bo2W1hkCvcW6wt8ppegyloaxDODO0URafvdU6uiziyVL3FJSVph8B7jITR4g3FlrACeQMoXHrj4sgxPM9x1yer5RFbZxUW5Zpij--nLoOf5CbaYAKmty8KrmZ-hyW0c6XPUyGaZfokwSZVKWZgKFqXEhKA_BVGSyFgGbc1k1ETvy5Pj0hVVh94eX3luXFHK4Zy5O-cm2quw50Uxkb_gdYAIKhwoAZ7_MFtccMdReJvESiZBLFOrVSbgTtQ6lszXhAqZUr-JdoCEeJFPWzEyfsh8AlUOQ9ZE73IMYGV20VK4jAy7dSgKVsPcrmHK-fSK34C2alDLoGRt8K4j4v9sulVSOHd8dMl_3fomeluBYQKIDcz0bJ3jRAmxKBbnRXEhqolCCg0WYHRcuyq1v7YOyaaXeZV1lkQ0Dsmrfy9rB93vT0ZDPhyMT7bRA9gQRCgGSQs1Vou1fm1V1lX6xjEGjPgts6KfxBCmeQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1BpDTEgIwbiVFWakTTygqI0TJ84DQltLtbILExqob5bj2FsllHS9aOKzeOTvOCdxwoK4PO215zi26-Nz87kQssP7AeO6bzwVZ9wLU2U9lUXWS4zhJua-thwTnI9PooPP4YcJn6yRH3UuDIZV1jyxZNRZodFH3sNILBBGkR_1rAuLOB2O3s0uPewghS-tdTuNikQOzbcrMN8Wb8dDOOtdxkbvzwYHnusw4GkeJUvPhtaCTQRGGki1VHAVCKt5AFI40lb5Qvdj63OV-VbYWABiqkKtmdJKZFkiAvjsLXI7DsIQu0bEk8bWA7FQNvv1Y5_hCymrY-45R3cD62G-JxNBSxqWTQMa0XDnAo3yq-mfVN_fIzivicTRA3Lf6bJ0ryK-h2TNzjfJxrF7rd8k9yqfIK1SnR6R70Os0usabFGVZ3Q4X53TT2aBSixQHy0s3a_KR8N3T0E5LYC-F7SmIZNR9BvTI2zthuPqKAF6hsledOwiy3I6zenApamXE4GaS6tCzTjH4OOX8dDzEwqYCGmtC-DNzI_J2U0c6BOynhe5eUZomGZZKoJUiSgNbYCaE4uSRMea9Y3QUYe8qU9OaldOHbt6fJWlWcW5xHOW7pw7ZLfBnlVlRP6Ct49E0OBg8e_yh2J-Lh0vkf0wznTCYp2CPpmgI9GYWAvfhFzplPsdso0kJKtM2oaFyT3hh1jfMBAd8rrEQCYGi9bK5WLA1rEcWAtzq4WpZ9NLeQ3abUGBNenW4B1HxP_ZdLemcOk46EL-uu8d8qoB4wQYFZibYlXiREkIKIDztLoQzUQBx9YKODpuXZXWX9uG5NOLsr66SCIOd_r5v5e1TTaAAcmj8cnhFrmL-8HQRJZ0yfpyvjIvQFddpi9LrkCJvGEu9BMuFKQV
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distribution+and+Drug+Resistance+of+Bacterial+Pathogens+Associated+with+Lower+Respiratory+Tract+Infection+in+Children+and+the+Effect+of+COVID-19+on+the+Distribution+of+Pathogens&rft.jtitle=The+Canadian+journal+of+infectious+diseases+%26+medical+microbiology&rft.au=Zhu%2C+Xuan&rft.au=Ye%2C+Ting&rft.au=Zhong%2C+Hong&rft.au=Luo%2C+Yaxuan&rft.date=2022-03-29&rft.issn=1712-9532&rft.volume=2022&rft.spage=1181283&rft_id=info:doi/10.1155%2F2022%2F1181283&rft_id=info%3Apmid%2F35368516&rft.externalDocID=35368516
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1712-9532&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1712-9532&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1712-9532&client=summon